Equities

New Ray Medicine International Holding Ltd

New Ray Medicine International Holding Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)0.053
  • Today's Change0.00 / 0.00%
  • Shares traded352.00k
  • 1 Year change-18.46%
  • Beta-0.5021
Data delayed at least 15 minutes, as of Jun 07 2024 08:46 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

New Ray Medicine International Holding Limited is an investment holding company principally engaged in the trading of pharmaceutical products in China. The Company operates its business through four segments. The Injection Drugs segment is engaged in the trading of injection drugs. The Capsule and Granule Drugs segment is engaged in the trading of capsule and granule drugs. The Tablet Drugs segment is engaged in the trading of tablet drugs. The Others segment is engaged in the trading of miscellaneous types of goods and drugs.

  • Revenue in HKD (TTM)50.15m
  • Net income in HKD-22.17m
  • Incorporated2012
  • Employees23.00
  • Location
    New Ray Medicine International Holding LtdRoom 3702-03, Dikai International CenterNo. 19 Dangui RoadHANGZHOU ChinaCHN
  • Websitehttp://www.newraymedicine.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Universal Health Intl Group Holding Ltd1.18bn-88.64m34.05m1.62k--0.098--0.0289-0.1421-0.14211.840.52061.355.738.99461,225.30-10.25-25.53-22.86-33.6816.1714.18-7.58-22.510.4672-6.310.1105--1.84--43.83------
China Healthwise Holdings Ltd146.32m-134.56m38.52m100.00--8.76--0.2633-0.1746-0.17460.18990.00570.66911.5525.841,463,170.00-61.54---122.54--41.21---91.96--0.585-0.25520.9612--3.00---147.92------
China NT Pharma Group Company Ltd7.95m-36.16m55.46m16.00------6.97-0.0183-0.07840.0038-0.13880.0115.870.337497,086.80-5.02-12.34---163.52710.06---454.67-128.280.0185--64.15-----58.1233.07---46.32--
Pa Shun International Holdings Ltd139.75m2.54m82.60m90.0032.62--13.520.5910.00170.00170.0948-0.0850.75552.976.981,552,791.001.37-41.00---68.5122.747.031.82-61.220.27281.993.33--80.30-30.89105.42---71.41--
China Ever Grand Financl Lasng Gp Co Ltd52.70m-40.41m91.11m62.00--0.2012--1.73-0.024-0.02290.03120.26840.08082.133.59850,032.30-6.20-9.34-8.31-16.1733.728.95-76.67-140.711.59-227.390.00---26.54-10.25-27.68---22.87--
New Ray Medicine International Holding50.15m-22.17m91.95m23.00--0.1915--1.83-0.0133-0.01330.030.28730.09731.170.36582,180,609.00-4.30-6.86-4.36-7.0722.614.24-44.20-29.8162.47--0.0006---44.13-33.0371.56---64.84--
Kingworld Medicines Group Ltd1.16bn41.13m348.60m1.00k8.050.52163.950.29930.06960.06961.971.070.82947.8913.471,162,350.004.744.078.578.0026.0229.725.715.591.02--0.336341.8312.63-0.003467.52-1.4654.829.24
Data as of Jun 07 2024. Currency figures normalised to New Ray Medicine International Holding Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.